Refill Reminder Programs May Be Next Free Speech Battleground For Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
Adheris sues HHS, arguing rule requiring patient authorization of Rx refill reminders violates its First Amendment rights; complaint may test scope of Supreme Court’s Sorrell ruling.
You may also be interested in...
Medication Adherence: A Positive Story You Are Not Hearing
Pharmaceutical companies are spending more to help patients adhere to their therapeutic regimens – an almost universally recognized way to improve health outcomes and pharma’s bottom line. But an unclear legal and regulatory climate and poor understanding of the adherence problems it is trying to solve means industry isn’t trumpeting what could be one of its best health care value arguments.
Rx Data Mining Opponents Will Need New Pitch After Supreme Court Strikes Down Vermont Law
The court affirms the Second Circuit's ruling that a Vermont statute prohibiting drug companies from using Rx data to market to doctors imposes an impermissible restriction on free speech.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.